| http://www.w3.org/ns/prov#value | - Lucentis was created by tweaking the molecular structure of another, older drug Avastin, which itself was originally approved for colorectal cancer but now has been approved for certain kinds of lung cancer, and has been submitted to Food and Drug Administration to be used against breast cancer and possible kidney cancer as well.
|
